BioLineRx (BLRX) Debt to Equity (2024 - 2025)

Generated on {Timestamp} © BusinessQuant.com

Generated on {Timestamp} Powered by

BioLineRx has reported Debt to Equity over the past 2 years, most recently at $0.49 for Q4 2025.

• Quarterly results put Debt to Equity at $0.49 for Q4 2025, down 50.79% from a year ago — trailing twelve months through Dec 2025 was $0.49 (down 50.79% YoY), and the annual figure for FY2025 was $0.49, down 50.79%.
• Debt to Equity for Q4 2025 was $0.49 at BioLineRx, down from $1.0 in the prior quarter.
• Over the last five years, Debt to Equity for BLRX hit a ceiling of $1.0 in Q4 2024 and a floor of $0.49 in Q4 2025.

Peer Comparison